What Is Cardiometabolic Health and Why Is It Important?

Cardiometabolic health refers to how well your body manages a set of interconnected processes: blood sugar regulation, blood pressure, cholesterol and triglyceride levels, and body fat distribution. When these systems work smoothly together, your risk of heart disease, stroke, and type 2 diabetes stays low. When they don’t, the problems reinforce each other in ways that go well beyond any single risk factor. What makes this framing useful, and what makes it alarming, is that by recent estimates only about 7% of American adults meet the criteria for optimal cardiometabolic health.

Why So Few People Qualify

That 7% figure comes from a large analysis of U.S. adults using national survey data through 2018, and it had been declining over the prior two decades.¹ The criteria are straightforward: healthy levels of blood pressure, blood sugar, cholesterol, triglycerides, and waist circumference, without needing medication to get there. You don’t have to be perfect on every measure. But you do have to be in a healthy range on all of them simultaneously, which turns out to be remarkably hard in a modern food environment.

An earlier analysis using stricter, updated cutoffs put the number even lower, at about 12% of adults, and found that less than a third of normal-weight adults qualified as metabolically healthy.² Among people classified as overweight, the rate dropped to 8%, and among those classified as obese it fell below 1%. The takeaway is that cardiometabolic health is not a binary switch flipped by body weight alone. Plenty of people at a normal weight have metabolic problems, and virtually no one with obesity escapes them entirely.

Insulin Resistance Ties It All Together

If there is a single thread running through poor cardiometabolic health, it is insulin resistance. Insulin is the hormone that tells your cells to take up glucose from the blood. When cells stop responding to it efficiently, your pancreas has to produce more and more insulin to keep blood sugar in check. Over time, this overtaxed system leads to elevated blood sugar, abnormal cholesterol profiles, higher blood pressure, and increased fat storage, especially around the organs.³

The downstream effects are wide-ranging. Insulin resistance promotes chronic low-grade inflammation, damages the inner lining of blood vessels, pushes lipid levels in unhealthy directions, and encourages the body to store fat in the worst possible places.⁴ It also shows up in conditions you might not immediately connect to heart health, including fatty liver disease and polycystic ovary syndrome.⁵ This is why researchers increasingly treat cardiometabolic health as one integrated system rather than a checklist of separate diseases.

Where Your Fat Sits Matters More Than How Much You Carry

Not all body fat behaves the same way. Fat stored deep in the abdomen, wrapped around the liver, intestines, and kidneys (visceral fat), is far more metabolically active and more harmful than the fat stored just under the skin (subcutaneous fat). Visceral fat pumps out inflammatory signals, disrupts insulin signaling, and is more tightly linked to the cluster of risk factors that define poor cardiometabolic health.⁶

The Framingham Heart Study found that visceral fat was a stronger predictor of metabolic syndrome than subcutaneous fat across both sexes. Among women, each standard-deviation increase in visceral fat carried roughly 4.7 times higher odds of metabolic syndrome, compared with 3.0 times for subcutaneous fat. The pattern was similar in men. Even after accounting for BMI and waist circumference, visceral fat independently predicted risk factors like high blood pressure and impaired fasting glucose.⁷

This distinction matters in young people too. In a study of youth, visceral fat was linked to higher fasting insulin, higher triglycerides, and lower HDL cholesterol, and the associations were generally stronger than those seen with subcutaneous fat.⁸ This is part of why waist circumference, which roughly tracks visceral fat, is included in cardiometabolic assessments. Two people at the same weight can have very different risk profiles depending on where their fat is distributed.

How Risk Factors Compound

One of the most important things to understand about cardiometabolic health is that individual risk factors don’t just add up; they multiply. A study of over 200,000 people found that having just one cardiometabolic risk factor (high blood pressure, high blood sugar, abnormal cholesterol, or excess weight) roughly doubled the odds of having had a heart attack or stroke. Two risk factors nearly tripled it. Five risk factors increased the odds nearly sixfold. The most dangerous combination was diabetes, hypertension, and abnormal cholesterol together.⁹

The specific cardiovascular consequences also vary depending on which risk factors you carry. Diabetes, for instance, appears to raise the risk of stroke more sharply than it raises the risk of coronary heart disease, while high LDL cholesterol has a stronger association with coronary heart disease than with stroke.¹⁰ High blood pressure, by contrast, raises both roughly equally. This is why comprehensive screening matters. Addressing only the most obvious risk factor while ignoring others leaves significant danger on the table.

Damage Beyond the Heart and Blood Vessels

The word “cardio” in cardiometabolic can be misleading. Poor cardiometabolic health affects far more than just the heart. Chronic inflammation and insulin resistance damage the inner lining of blood vessels throughout the body, a process that accelerates atherosclerosis, the buildup of fatty plaques in artery walls.¹¹ But the same metabolic dysfunction also harms organs that don’t make headlines as often.

The liver is one of the first casualties. Metabolic dysfunction-associated steatotic liver disease (the updated name for what used to be called non-alcoholic fatty liver disease) shares the same underlying drivers: insulin resistance, excess visceral fat, and chronic inflammation. Researchers now describe cardiovascular disease, metabolic syndrome, and fatty liver disease as overlapping consequences of the same breakdown in metabolic health.¹²

The kidneys are similarly vulnerable. Metabolic syndrome has been clearly linked to markers of chronic kidney disease, including reduced filtering capacity and protein leaking into the urine, as well as structural changes in kidney tissue.¹³ This creates a vicious cycle: damaged kidneys worsen blood pressure and fluid balance, which in turn accelerates cardiovascular decline.

Dietary Patterns That Improve Cardiometabolic Health

Two dietary patterns have the strongest evidence base for improving cardiometabolic markers: the DASH diet (originally designed to lower blood pressure) and the Mediterranean diet. An umbrella review of systematic reviews and meta-analyses found that the DASH pattern was linked to about a 20% lower risk of cardiovascular disease, coronary heart disease, stroke, and diabetes in large observational studies. In controlled trials, it reduced systolic blood pressure by roughly 5 mmHg, lowered total and LDL cholesterol, improved blood sugar control, and led to modest weight loss.¹⁴

A randomized trial comparing DASH and Mediterranean diets with salt restriction against a control group found that both dietary interventions dramatically reduced the odds of metabolic syndrome. The Mediterranean diet group had about an 85% lower likelihood of metabolic syndrome compared to controls, and the DASH group about 70% lower. Both also reduced total cholesterol, LDL cholesterol, fasting glucose, and blood pressure.¹⁵ The two diets share a lot of ground: both emphasize fruits, vegetables, whole grains, nuts, and lean protein while limiting processed foods, added sugars, and excess sodium. The Mediterranean version adds olive oil and moderate wine as distinguishing features, but the metabolic payoff is broadly similar.

One wrinkle worth knowing: the age at which you adopt these patterns may matter. An analysis of U.S. adults found that higher adherence to the Mediterranean diet and DASH pattern was more strongly associated with favorable metabolic profiles in younger adults (under 45 for men, premenopausal for women) than in older groups.¹⁶ That doesn’t mean dietary changes are useless later in life, but it does suggest that establishing good eating habits earlier pays larger dividends.

What Kind of Exercise Helps Most

Exercise is one of the most reliable ways to improve insulin sensitivity and nearly every cardiometabolic marker. But the type of exercise matters more than most people assume. A study of inactive middle-aged men with excess body weight compared aerobic training, resistance training, and a combination of both over a structured program. Resistance training and combined training produced bigger drops in fasting blood glucose and blood pressure than aerobic training alone. Resistance training also improved insulin resistance more than aerobic training did. Aerobic and combined training, on the other hand, were better at reducing waist-to-hip ratio.¹⁷

The practical implication is that a mix of both resistance and aerobic exercise covers the widest range of cardiometabolic benefits. Running or cycling alone won’t deliver the same blood sugar improvements as adding some strength work, and lifting alone won’t trim visceral fat as effectively as adding some cardio. The combined approach consistently showed strong results across nearly every metric measured.

Sleep, Circadian Disruption, and Stress

Sleep is increasingly recognized as a cardiometabolic risk factor in its own right, and not just because of sleep quantity. When your internal circadian clock falls out of sync with your environment, as routinely happens with shift work, jet lag, or irregular sleep schedules, the metabolic consequences can be significant. Researchers have identified circadian disruption as a risk factor for cardiovascular disease, diabetes, and obesity, driven by misalignment between internal rhythms and the timing of eating, sleeping, and light exposure.¹⁸

Chronic psychological stress compounds the problem through a different pathway. Stress activates the body’s cortisol response, and sustained elevations in cortisol promote fat accumulation (especially visceral fat), abnormal cholesterol, and higher blood sugar. Alterations in morning cortisol levels and the normal daily cortisol rhythm have been linked to adiposity, abnormal lipids, incident diabetes, and hypertension.¹⁹ The stress-cortisol-metabolism connection is one reason why cardiometabolic disease tracks so closely with socioeconomic disadvantage, a point that comes up again when you look at the social determinants of this condition.

Social Determinants and Health Equity

Cardiometabolic health is shaped by far more than individual choices. Where you live, how much money you make, what kind of work you do, and how much discrimination you face all influence your metabolic trajectory. Social determinants of health, including economic stability, environmental exposures, community factors, and psychosocial stress, affect every stage of cardiometabolic disease, from initial prevention through ongoing management.²⁰

These are not just loose associations. The molecular pathways linking social disadvantage to cardiometabolic disease are becoming clearer: chronic stress alters cortisol regulation and inflammatory signaling, environmental pollutants disrupt metabolic function, and food insecurity pushes people toward cheap, calorie-dense, nutrient-poor diets.²¹ A study that clustered U.S. adults by social and behavioral characteristics found that the group with the worst social and behavioral profile had roughly 15 times the adjusted odds of undiagnosed diabetes compared to the healthiest cluster, and the disparities were consistent across racial and ethnic groups.²² That finding underscores a critical point: fixing cardiometabolic health at the population level requires more than telling individuals to eat better and exercise. It demands addressing the structural conditions that make healthy choices difficult or impossible for large segments of the population.

Newer Drug Classes With Cardiometabolic Benefits

For people who already have type 2 diabetes or established cardiovascular disease, two relatively newer drug classes have changed the treatment landscape. SGLT2 inhibitors (which work by causing the kidneys to excrete excess glucose) and GLP-1 receptor agonists (which mimic a gut hormone that regulates blood sugar and appetite) both improve blood sugar control, but their importance goes well beyond glucose. Both classes have demonstrated benefits for cardiovascular outcomes and kidney protection in high-risk patients.²³

Combining the two classes appears to offer advantages beyond what either achieves alone, improving HbA1c (a long-term blood sugar marker), body weight, and blood pressure, with potential benefits for residual cardiovascular risk that persists even after standard treatment.²⁴ GLP-1 receptor agonists in particular have attracted enormous public attention because of their striking effects on weight loss (semaglutide, sold as Ozempic and Wegovy, belongs to this class). But their cardiometabolic benefits extend beyond the scale: they reduce inflammation, improve lipid profiles, and lower blood pressure through mechanisms that appear at least partly independent of weight loss itself.²⁵

Better Biomarkers Than Standard Cholesterol

Standard lipid panels measure the cholesterol carried inside lipoprotein particles, but a growing body of evidence suggests that counting the particles themselves gives a more accurate picture of cardiovascular risk. Apolipoprotein B (apoB) is a protein found on every atherogenic lipoprotein particle. In a cohort of men, apoB in the top fifth of the distribution carried about three times the coronary heart disease risk of those in the bottom fifth, and when apoB and non-HDL cholesterol were statistically pitted against each other, only apoB remained a significant predictor.²⁶ A separate study in people with type 2 diabetes found that apoB predicted coronary artery calcification better than LDL cholesterol, total cholesterol, or common cholesterol ratios.²⁷

This matters for cardiometabolic health because people with insulin resistance often have a pattern where their LDL cholesterol looks normal on a standard panel, but they actually have a large number of small, dense LDL particles. In that scenario, LDL cholesterol (which measures the cholesterol cargo) understates the true risk, while apoB (which counts the particles) catches it. Continuous glucose monitors are another emerging tool. Even in people without diabetes, greater time spent within a healthy blood sugar range has been associated with lower estimated cardiovascular risk and better insulin sensitivity.²⁸ These technologies are nudging cardiometabolic monitoring toward earlier detection and more personalized intervention.

It Starts Before Birth

Cardiometabolic risk doesn’t begin in middle age. Research increasingly points to prenatal and early childhood conditions as powerful contributors. Both low and high birth weight, combined with certain postnatal growth patterns, are associated with cardiometabolic disease in adulthood. Babies born small who then grow rapidly, or babies born large who continue on an accelerated trajectory, appear to develop early vascular changes and metabolic risk factors that persist.²⁹

This idea, sometimes called developmental programming, fits within a broader evolutionary framework. The traits that helped our ancestors survive in environments of food scarcity, like efficient fat storage and strong insulin responses, can become liabilities in a world of cheap, abundant calories. What was once an advantage in famine becomes a vulnerability in an era of ultra-processed food and sedentary routines.³⁰ Understanding these deep roots doesn’t change anyone’s daily routine, but it does reframe cardiometabolic disease as something more fundamental than a failure of willpower. It’s a collision between biology shaped over millennia and an environment that changed in decades.

The Gut Microbiome Connection

Your gut bacteria are turning out to be more relevant to cardiometabolic health than anyone expected a generation ago. When gut microbes ferment dietary fiber, they produce short-chain fatty acids, small molecules that improve the integrity of the gut lining, help regulate blood sugar and lipid metabolism, modulate the immune system, and influence blood pressure.³¹ Diets rich in fiber and omega-3 fatty acids increase both the production of these beneficial molecules and the abundance of the bacterial species that make them. Diets heavy in processed food do the opposite, reducing microbial diversity and short-chain fatty acid output. This creates a feedback loop: a poor diet shifts the gut microbiome toward a less favorable composition, which in turn worsens the metabolic response to that same diet. Researchers are exploring whether deliberately increasing short-chain fatty acid production, through dietary fiber, prebiotics, or targeted probiotics, could become a mainstream strategy for cardiometabolic risk reduction. The evidence is promising but still early, and the field is far enough from clinical application that no one should be treating a gut supplement as a substitute for the dietary and exercise changes that already have decades of solid data behind them.